Literature DB >> 24739573

Unravelling mechanisms of p53-mediated tumour suppression.

Kathryn T Bieging1, Stephano Spano Mello1, Laura D Attardi2.   

Abstract

p53 is a crucial tumour suppressor that responds to diverse stress signals by orchestrating specific cellular responses, including transient cell cycle arrest, cellular senescence and apoptosis, which are all processes associated with tumour suppression. However, recent studies have challenged the relative importance of these canonical cellular responses for p53-mediated tumour suppression and have highlighted roles for p53 in modulating other cellular processes, including metabolism, stem cell maintenance, invasion and metastasis, as well as communication within the tumour microenvironment. In this Opinion article, we discuss the roles of classical p53 functions, as well as emerging p53-regulated processes, in tumour suppression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739573      PMCID: PMC4049238          DOI: 10.1038/nrc3711

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  186 in total

Review 1.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

Review 2.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

3.  DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.

Authors:  Katharina Schlereth; Rasa Beinoraviciute-Kellner; Marie K Zeitlinger; Anne C Bretz; Markus Sauer; Joël P Charles; Fotini Vogiatzi; Ellen Leich; Birgit Samans; Martin Eilers; Caroline Kisker; Andreas Rosenwald; Thorsten Stiewe
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; George Trimis; Matrisa Frangou-Plemmenou; Agatha Pafiti-Kondi; Anastasios Kalofoutis
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

Review 6.  Interactions between the tumor suppressor p53 and immune responses.

Authors:  Daniel Menendez; Maria Shatz; Michael A Resnick
Journal:  Curr Opin Oncol       Date:  2013-01       Impact factor: 3.645

7.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

8.  Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.

Authors:  S Rowan; R L Ludwig; Y Haupt; S Bates; X Lu; M Oren; K H Vousden
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

9.  Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases.

Authors:  Karine Lefort; Anna Mandinova; Paola Ostano; Vihren Kolev; Valerie Calpini; Ingrid Kolfschoten; Vikram Devgan; Jocelyn Lieb; Wassim Raffoul; Daniel Hohl; Victor Neel; Jonathan Garlick; Giovanna Chiorino; G Paolo Dotto
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

10.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

View more
  518 in total

1.  Cathepsin-Mediated Cleavage of Peptides from Peptide Amphiphiles Leads to Enhanced Intracellular Peptide Accumulation.

Authors:  Handan Acar; Ravand Samaeekia; Mathew R Schnorenberg; Dibyendu K Sasmal; Jun Huang; Matthew V Tirrell; James L LaBelle
Journal:  Bioconjug Chem       Date:  2017-08-24       Impact factor: 4.774

Review 2.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

3.  SETD1A induced miRNA network suppresses the p53 gene expression module.

Authors:  Toshifumi Yae; Ken Tajima; Shyamala Maheswaran
Journal:  Cell Cycle       Date:  2016-02-11       Impact factor: 4.534

Review 4.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

5.  A genome-wide analysis of colorectal cancer in a child with Noonan syndrome.

Authors:  Rahul M Prasad; Rajen J Mody; George Myers; Melisa Mullins; Zaher Naji; James D Geiger
Journal:  Pediatr Blood Cancer       Date:  2018-07-24       Impact factor: 3.167

6.  Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Authors:  L Palanikumar; Laura Karpauskaite; Mohamed Al-Sayegh; Ibrahim Chehade; Maheen Alam; Sarah Hassan; Debabrata Maity; Liaqat Ali; Mona Kalmouni; Yamanappa Hunashal; Jemil Ahmed; Tatiana Houhou; Shake Karapetyan; Zackary Falls; Ram Samudrala; Renu Pasricha; Gennaro Esposito; Ahmed J Afzal; Andrew D Hamilton; Sunil Kumar; Mazin Magzoub
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

Review 7.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

8.  p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis.

Authors:  Nicholas W Fischer; Aaron Prodeus; David Malkin; Jean Gariépy
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

Review 9.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Hypertonic Saline Primes Activation of the p53-p21 Signaling Axis in Human Small Airway Epithelial Cells That Prevents Inflammation Induced by Pro-inflammatory Cytokines.

Authors:  Fabia Gamboni; Cameron Anderson; Sanchayita Mitra; Julie A Reisz; Travis Nemkov; Monika Dzieciatkowska; Kenneth L Jones; Kirk C Hansen; Angelo D'Alessandro; Anirban Banerjee
Journal:  J Proteome Res       Date:  2016-08-29       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.